CF Industries Holdings, Inc.

LSE:0HQU Stock Report

Market Cap: US$15.4b

CF Industries Holdings Valuation

Is 0HQU undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0HQU when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0HQU ($88.31) is trading below our estimate of fair value ($158.56)

Significantly Below Fair Value: 0HQU is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0HQU?

Key metric: As 0HQU is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0HQU. This is calculated by dividing 0HQU's market cap by their current earnings.
What is 0HQU's PE Ratio?
PE Ratio13.3x
EarningsUS$1.16b
Market CapUS$15.43b

Price to Earnings Ratio vs Peers

How does 0HQU's PE Ratio compare to its peers?

The above table shows the PE ratio for 0HQU vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24.7x
CRDA Croda International
29.9x15.1%UK£4.9b
ANTO Antofagasta
27.2x18.5%UK£16.4b
SMDS DS Smith
20.9x8.3%UK£8.0b
JMAT Johnson Matthey
20.8x28.6%UK£2.2b
0HQU CF Industries Holdings
13.3x-6.6%US$15.4b

Price-To-Earnings vs Peers: 0HQU is good value based on its Price-To-Earnings Ratio (13.3x) compared to the peer average (24.7x).


Price to Earnings Ratio vs Industry

How does 0HQU's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0HQU 13.3xIndustry Avg. 17.3xNo. of Companies13PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0HQU is good value based on its Price-To-Earnings Ratio (13.3x) compared to the European Chemicals industry average (17.3x).


Price to Earnings Ratio vs Fair Ratio

What is 0HQU's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0HQU PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.3x
Fair PE Ratio13.5x

Price-To-Earnings vs Fair Ratio: 0HQU is good value based on its Price-To-Earnings Ratio (13.3x) compared to the estimated Fair Price-To-Earnings Ratio (13.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0HQU forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$88.31
US$87.04
-1.4%
10.0%US$105.00US$69.00n/a20
Nov ’25US$84.18
US$86.94
+3.3%
10.2%US$105.00US$69.00n/a20
Oct ’25US$87.27
US$84.59
-3.1%
8.9%US$100.00US$69.00n/a20
Sep ’25US$82.76
US$83.89
+1.4%
9.5%US$100.00US$67.00n/a20
Aug ’25US$76.04
US$80.49
+5.8%
8.2%US$95.00US$67.00n/a20
Jul ’25US$73.61
US$82.44
+12.0%
9.0%US$96.00US$67.00n/a20
Jun ’25US$78.70
US$82.32
+4.6%
8.6%US$96.00US$69.00n/a21
May ’25US$77.80
US$85.26
+9.6%
7.9%US$100.00US$69.00n/a22
Apr ’25US$83.10
US$86.06
+3.6%
9.2%US$100.00US$68.00n/a21
Mar ’25US$82.28
US$86.06
+4.6%
9.2%US$100.00US$68.00n/a21
Feb ’25US$76.87
US$86.50
+12.5%
10.0%US$100.00US$68.00n/a20
Jan ’25US$79.39
US$88.50
+11.5%
11.4%US$105.00US$68.00n/a20
Dec ’24US$76.06
US$88.75
+16.7%
11.0%US$105.00US$68.00n/a20
Nov ’24US$79.32
US$89.30
+12.6%
10.8%US$105.00US$68.00US$84.1820
Oct ’24US$85.69
US$87.95
+2.6%
10.7%US$105.00US$67.00US$87.2720
Sep ’24US$78.39
US$86.95
+10.9%
11.1%US$105.00US$67.00US$82.7621
Aug ’24US$81.22
US$84.19
+3.7%
13.9%US$105.00US$65.00US$76.0421
Jul ’24US$70.16
US$86.15
+22.8%
15.3%US$110.00US$65.00US$73.6121
Jun ’24US$61.05
US$86.96
+42.4%
15.2%US$110.00US$65.00US$78.7021
May ’24US$70.67
US$93.43
+32.2%
13.8%US$115.00US$70.00US$77.8021
Apr ’24US$72.36
US$101.29
+40.0%
12.9%US$126.00US$75.00US$83.1021
Mar ’24US$86.06
US$101.57
+18.0%
12.8%US$126.00US$75.00US$82.2821
Feb ’24US$85.11
US$109.14
+28.2%
14.2%US$132.00US$75.00US$76.8721
Jan ’24US$84.92
US$115.30
+35.8%
12.9%US$135.00US$80.00US$79.3920
Dec ’23US$105.21
US$115.30
+9.6%
12.9%US$135.00US$80.00US$76.0620
Nov ’23US$107.85
US$114.20
+5.9%
13.5%US$135.00US$78.00US$79.3220

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies